128 related articles for article (PubMed ID: 10911737)
1. Photodynamic therapy of human glioma spheroids using 5-aminolevulinic acid.
Madsen SJ; Sun CH; Tromberg BJ; Wallace VP; Hirschberg H
Photochem Photobiol; 2000 Jul; 72(1):128-34. PubMed ID: 10911737
[TBL] [Abstract][Full Text] [Related]
2. Repetitive 5-aminolevulinic acid-mediated photodynamic therapy on human glioma spheroids.
Madsen SJ; Sun CH; Tromberg BJ; Hirschberg H
J Neurooncol; 2003 May; 62(3):243-50. PubMed ID: 12777075
[TBL] [Abstract][Full Text] [Related]
3. Development of a novel indwelling balloon applicator for optimizing light delivery in photodynamic therapy.
Madsen SJ; Sun CH; Tromberg BJ; Hirschberg H
Lasers Surg Med; 2001; 29(5):406-12. PubMed ID: 11891728
[TBL] [Abstract][Full Text] [Related]
4. Effects of ALA-mediated photodynamic therapy on the invasiveness of human glioma cells.
Hirschberg H; Sun CH; Krasieva T; Madsen SJ
Lasers Surg Med; 2006 Dec; 38(10):939-45. PubMed ID: 17163479
[TBL] [Abstract][Full Text] [Related]
5. Motexafin gadolinium enhances the efficacy of aminolevulinic acid mediated-photodynamic therapy in human glioma spheroids.
Madsen SJ; Mathews MS; Angell-Petersen E; Sun CH; Vo V; Sanchez R; Hirschberg H
J Neurooncol; 2009 Jan; 91(2):141-9. PubMed ID: 18777009
[TBL] [Abstract][Full Text] [Related]
6. The effects of ultra low fluence rate single and repetitive photodynamic therapy on glioma spheroids.
Mathews MS; Angell-Petersen E; Sanchez R; Sun CH; Vo V; Hirschberg H; Madsen SJ
Lasers Surg Med; 2009 Oct; 41(8):578-84. PubMed ID: 19731298
[TBL] [Abstract][Full Text] [Related]
7. Acute morphological sequelae of photodynamic therapy with 5-aminolevulinic acid in the C6 spheroid model.
Zelenkov P; Baumgartner R; Bise K; Heide M; Meier R; Stocker S; Sroka R; Goldbrunner R; Stummer W
J Neurooncol; 2007 Mar; 82(1):49-60. PubMed ID: 17004102
[TBL] [Abstract][Full Text] [Related]
8. Morphological and histological changes of glioma cells immediately after 5-aminolevulinic acid mediated photodynamic therapy.
Kamoshima Y; Terasaka S; Kuroda S; Iwasaki Y
Neurol Res; 2011 Sep; 33(7):739-46. PubMed ID: 21756554
[TBL] [Abstract][Full Text] [Related]
9. [Photodynamic therapy mediated with 5-aminolevulinic acid for C6 glioma spheroids].
Kamoshima Y; Terasaka S; Iwasaki Y
Hokkaido Igaku Zasshi; 2008 May; 83(3):167-73. PubMed ID: 18546870
[TBL] [Abstract][Full Text] [Related]
10. ALA- and ALA-ester-mediated photodynamic therapy of human glioma spheroids.
Hirschberg H; Sun CH; Tromberg BJ; Madsen SJ
J Neurooncol; 2002 Mar; 57(1):1-7. PubMed ID: 12125962
[TBL] [Abstract][Full Text] [Related]
11. Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect.
Robinson DJ; de Bruijn HS; de Wolf WJ; Sterenborg HJ; Star WM
Photochem Photobiol; 2000 Dec; 72(6):794-802. PubMed ID: 11140268
[TBL] [Abstract][Full Text] [Related]
12. Repetitive photodynamic therapy of malignant brain tumors.
Hirschberg H; Sørensen DR; Angell-Petersen E; Peng Q; Tromberg B; Sun CH; Spetalen S; Madsen S
J Environ Pathol Toxicol Oncol; 2006; 25(1-2):261-79. PubMed ID: 16566723
[TBL] [Abstract][Full Text] [Related]
13. Modulation of migratory activity and invasiveness of human glioma spheroids following 5-aminolevulinic acid-based photodynamic treatment. Laboratory investigation.
Etminan N; Peters C; Ficnar J; Anlasik S; Bünemann E; Slotty PJ; Hänggi D; Steiger HJ; Sorg RV; Stummer W
J Neurosurg; 2011 Aug; 115(2):281-8. PubMed ID: 21513432
[TBL] [Abstract][Full Text] [Related]
14. Heat-shock protein 70-dependent dendritic cell activation by 5-aminolevulinic acid-mediated photodynamic treatment of human glioblastoma spheroids in vitro.
Etminan N; Peters C; Lakbir D; Bünemann E; Börger V; Sabel MC; Hänggi D; Steiger HJ; Stummer W; Sorg RV
Br J Cancer; 2011 Sep; 105(7):961-9. PubMed ID: 21863026
[TBL] [Abstract][Full Text] [Related]
15. Tunable phosphatase-sensitive stable prodrugs of 5-aminolevulinic acid for tumor fluorescence photodetection.
Babič A; Herceg V; Ateb I; Allémann E; Lange N
J Control Release; 2016 Aug; 235():155-164. PubMed ID: 27235981
[TBL] [Abstract][Full Text] [Related]
16. Dose and timing of the first light fraction in two-fold illumination schemes for topical ALA-mediated photodynamic therapy of hairless mouse skin.
Robinson DJ; de Bruijn HS; Star WM; Sterenborg HJ
Photochem Photobiol; 2003 Mar; 77(3):319-23. PubMed ID: 12685661
[TBL] [Abstract][Full Text] [Related]
17. Low-fluence rate, long duration photodynamic therapy in glioma mouse model using organic light emitting diode (OLED).
Guo HW; Lin LT; Chen PH; Ho MH; Huang WT; Lee YJ; Chiou SH; Hsieh YS; Dong CY; Wang HW
Photodiagnosis Photodyn Ther; 2015 Sep; 12(3):504-10. PubMed ID: 25936596
[TBL] [Abstract][Full Text] [Related]
18. 5-Aminolevulinic acid-mediated photodynamic therapy can target human glioma stem-like cells refractory to antineoplastic agents.
Fujishiro T; Nonoguchi N; Pavliukov M; Ohmura N; Kawabata S; Park Y; Kajimoto Y; Ishikawa T; Nakano I; Kuroiwa T
Photodiagnosis Photodyn Ther; 2018 Dec; 24():58-68. PubMed ID: 29990642
[TBL] [Abstract][Full Text] [Related]
19. Imaging of hypoxia, oxygen consumption and recovery in vivo during ALA-photodynamic therapy using delayed fluorescence of Protoporphyrin IX.
Scholz M; Petusseau AF; Gunn JR; Shane Chapman M; Pogue BW
Photodiagnosis Photodyn Ther; 2020 Jun; 30():101790. PubMed ID: 32344195
[TBL] [Abstract][Full Text] [Related]
20. Protoporphyrin IX fluorescence photobleaching and the response of rat Barrett's esophagus following 5-aminolevulinic acid photodynamic therapy.
Boere IA; Robinson DJ; de Bruijn HS; Kluin J; Tilanus HW; Sterenborg HJ; de Bruin RW
Photochem Photobiol; 2006; 82(6):1638-44. PubMed ID: 16879035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
